cerebrolysin

**Cerebrolysin** is a proprietary, standardized porcine brain-derived preparation of low-molecular-weight peptides and free amino acids. It is administered parenterally as a solution for injection/infusion and is intended to provide neurotrophic, neuroprotective, and neuroregenerative effects in central nervous system disorders. Its precise active peptide constituents and clinically decisive molecular targets have not been definitively established; therefore, it should be regarded as a heterogeneous biological peptide mixture rather than a single defined molecular entity. EVER Pharma markets Cerebrolysin as a prescription medicine in certain countries for cerebrovascular disorders, including Alzheimer-type dementia, vascular dementia, stroke, and craniocerebral trauma. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37818733/))

Brand names

Cerebrolysin

Other names

porcine brain-derived neurotrophic peptidesporcine brain-derived amino acid mixture